Atlas Trials

Congenital FXIII Deficiency

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Congenital FXIII Deficiency

RecordFirmDate
A Study of Safety and Effectiveness of NovoThirteenĀ® (rFXIII) During Treatment of Congenital FXIII Deficiency in Japan (NCT02670213)Novo Nordisk A/S2016-03-16
Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency (NCT01253811)Novo Nordisk A/S2011-01-01
Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit Deficiency (NCT01230021)Novo Nordisk A/S2010-11-01
Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725 (NCT00978380)Novo Nordisk A/S2009-09-21
Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency (NCT00713648)Novo Nordisk A/S2008-08-01
Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers (NCT01848002)Novo Nordisk A/S2003-05-01
Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll Deficiency (NCT00056589)Novo Nordisk A/S2003-03-01
Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy Volunteers (NCT01847989)Novo Nordisk A/S2003-01-01

Track Congenital FXIII Deficiency automatically

Every clearance here is in the API, with alerts when new ones post.